Alternatives to Juno Therapeutics

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Genomics and AI-driven health intelligence company focused on extending healthy human life.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Developing novel immunotherapies and diagnostics for cancer.

Developing in vivo immunotherapies for autoimmune diseases and cancer.

Developing novel immunotherapies for cancer.

A biotechnology company focused on oncology drug discovery.

Biotechnology company developing novel immunotherapies for cancer.

Biotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

A clinical-stage biotechnology company developing novel bispecific and trispecific immunotherapies for the treatment of cancer.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

Immunotherapy company targeting oncology and autoimmune diseases.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Biopharmaceutical company developing T-cell therapies for solid tumor cancers.